Investor events
Find information on upcoming and past investor transactions.
Upcoming events
Interim Report for 1 January – 30 September 2024
Past events
Half-Year Financial Report for 1 January – 30 June 2024
Interim Report for 1 January – 31 March 2024
Financial Statement Bulletin for 1 January – 31 December 2023
Interim Report for 1 January – 30 September 2023
Half-Year Financial Report for 1 January – 30 June 2023
Redeye Diabetes Event
Interim Report for 1 January – 31 March 2023
Carnegie Nordic Healthcare seminar in Stockholm
SEB Finnish Small cap seminar
Financial Statement Bulletin for 1 January – 31 December 2022
Nordic American Life Science Conference in New York City 2022
Optomed Plc will release its Interim Report for 1 January – 30 September 2022
Optomed Plc will release its Half-Year Financial Report for 1 January – 30 June 2022
Optomed Plc will release its Interim Report for 1 January – 31 March 2021
Optomed Plc will release its Financial Statement Bulletin for 1 January – 31 December 2021
Kouvola investor event
CAR healthcare seminar
Nordea Innovation seminar
Danske Small & Midcap Day
Redeye Life Science Day
Optomed will participate Redeye Life Science Day.
Optomed will publish Q3-2021 Interim Report
Redeye Medtech & Diagnostics
Optomed will participate Redeye Medtech & Diagnostics.
Kepler Cheuvreux Autumn Conference 2021
Optomed will participate Kepler Cheuvreux Autumn Conference 2021.
Optomed will publish H1 2021 Financial Report
Red Eye Growth Day
Optomed will participate in Redeye’s Growth Day 2021 June 2nd.
Optomed will participate in ABGSC Life Science Summit 2021
Optomed will participate in Carnegie Ophthalmic Medtech seminar
Optomed Virtual Roadshow
Optomed Virtual Roadshow
Optomed will publish Q1-2021 interim report
Annual General Meeting
Optomed will publish Annual Report 2020
Optomed will participate in Carnegie Health Seminar
Optomed will publish Financial Statements Bulletin 2020
Optomed's Pre-Silent seminar with Carnegie
Q3 Interim Report
Optomed will publish its Q3-2020 financial report on 25 November 2020. The investor call will be held on the same date.
Finnish retail webinar
Optomed will participate the webinar of the Finnish Foundation for Share Promotion and the Finnish Society of Financial Analysts
The presentation of the CEO and founder Seppo Kopsala is available here (in Finnish): https://youtu.be/j1bEy7obsaM
H1 2020 Financial Report
Optomed will publish its H1-2020 financial report on 27 August 2020. The investor call will be held on the same date.
Annual General Meeting
Optomed’s Annual General Meeting was held in 11 June 2020.
Frankfurt Virtual Road Show
Optomed participated virtual Roadshow in Frankfurt
Redeye Growth Day
Optomed participated in Redeye’s Growth Day 2020 on June 2nd, 2020. The presentation of the CEO and founder Seppo Kopsala is available here: https://www.redeye.se/videoiframe/787418